Published in J Immunol on March 01, 2000
Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol (2007) 8.31
Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol (2008) 5.37
Cancer immunotherapy via dendritic cells. Nat Rev Cancer (2012) 5.37
Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev (2008) 5.28
Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet (2009) 4.97
Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab (2008) 4.61
Nonclassic actions of vitamin D. J Clin Endocrinol Metab (2008) 3.71
Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis (2007) 2.76
Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice. J Clin Invest (2008) 2.23
1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol (2009) 2.22
Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci U S A (2001) 2.14
Tuning microenvironments: induction of regulatory T cells by dendritic cells. Immunity (2008) 2.09
Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am (2010) 2.06
Designing vaccines based on biology of human dendritic cell subsets. Immunity (2010) 2.04
Dendritic cells in intestinal homeostasis and disease. J Clin Invest (2009) 1.83
Vitamin D: newly discovered actions require reconsideration of physiologic requirements. Trends Endocrinol Metab (2010) 1.68
Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes (2007) 1.68
The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respir Res (2011) 1.65
Vitamin D and host resistance to infection? Putting the cart in front of the horse. Exp Biol Med (Maywood) (2010) 1.59
Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. J Immunol (2009) 1.57
Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism. Nat Rev Nephrol (2009) 1.51
Vitamin D and the intracrinology of innate immunity. Mol Cell Endocrinol (2010) 1.50
Chronic obstructive pulmonary disease is associated with low levels of vitamin D. PLoS One (2012) 1.47
Altered endocrine and autocrine metabolism of vitamin D in a mouse model of gastrointestinal inflammation. Endocrinology (2008) 1.44
Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis. PLoS One (2015) 1.43
The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus. PLoS One (2010) 1.42
Extrarenal expression of the 25-hydroxyvitamin D-1-hydroxylase. Arch Biochem Biophys (2012) 1.41
The vitamin D-antimicrobial peptide pathway and its role in protection against infection. Future Microbiol (2009) 1.40
Does vitamin D affect risk of developing autoimmune disease?: a systematic review. Semin Arthritis Rheum (2010) 1.39
Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha,25-dihydroxyvitamin D3 abrogates regulatory function. J Clin Invest (2009) 1.35
Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses. J Immunol (2012) 1.35
Vitamin D and autoimmune thyroid diseases. Cell Mol Immunol (2011) 1.28
Pollen-associated phytoprostanes inhibit dendritic cell interleukin-12 production and augment T helper type 2 cell polarization. J Exp Med (2005) 1.27
Role of dendritic cells in the induction of regulatory T cells. Cell Biosci (2011) 1.27
Leprosy and the human genome. Microbiol Mol Biol Rev (2010) 1.27
Vitamin D3 attenuates Th2 responses to Aspergillus fumigatus mounted by CD4+ T cells from cystic fibrosis patients with allergic bronchopulmonary aspergillosis. J Clin Invest (2010) 1.27
Expansion of antigen-specific regulatory T cells with the topical vitamin d analog calcipotriol. J Immunol (2009) 1.26
No effect of the 1alpha,25-dihydroxyvitamin D3 on beta-cell residual function and insulin requirement in adults with new-onset type 1 diabetes. Diabetes Care (2010) 1.26
Regulatory dendritic cells: there is more than just immune activation. Front Immunol (2012) 1.25
Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. Physiol Rev (2016) 1.25
LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells. J Leukoc Biol (2008) 1.23
Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates. Am J Transplant (2013) 1.22
Exaptation of an ancient Alu short interspersed element provides a highly conserved vitamin D-mediated innate immune response in humans and primates. BMC Genomics (2009) 1.22
1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitis. PLoS One (2010) 1.22
1,25-Dihydroxyvitamin D inhibits lipopolysaccharide-induced immune activation in human endothelial cells. Clin Exp Immunol (2006) 1.22
Vitamin D receptor expression by the lung micro-environment is required for maximal induction of lung inflammation. Arch Biochem Biophys (2007) 1.19
Vitamin D deficiency in undifferentiated connective tissue disease. Arthritis Res Ther (2008) 1.19
Vitamin D insufficiency: implications for the immune system. Pediatr Nephrol (2010) 1.18
Endogenous dendritic cells mediate the effects of intravenously injected therapeutic immunosuppressive dendritic cells in transplantation. Blood (2010) 1.14
Vitamin D effects on lung immunity and respiratory diseases. Vitam Horm (2011) 1.12
Comparative study of clinical grade human tolerogenic dendritic cells. J Transl Med (2011) 1.12
Dietary influences on intestinal immunity. Nat Rev Immunol (2012) 1.11
Vitamin D metabolism and innate immunity. Mol Cell Endocrinol (2011) 1.11
Suppression of antigen-specific adaptive immunity by IL-37 via induction of tolerogenic dendritic cells. Proc Natl Acad Sci U S A (2014) 1.10
Thymic stromal lymphopoietin and thymic stromal lymphopoietin-conditioned dendritic cells induce regulatory T-cell differentiation and protection of NOD mice against diabetes. Diabetes (2008) 1.10
Vitamin D in inflammatory diseases. Front Physiol (2014) 1.10
Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now? Clin Exp Immunol (2013) 1.09
The effect of melanism and vitamin D synthesis on the incidence of autoimmune disease. Nat Clin Pract Rheumatol (2009) 1.07
Vitamin D and differentiation in cancer. Crit Rev Clin Lab Sci (2009) 1.05
Vitamin D3 correlates inversely with systemic dendritic cell numbers and bone erosion in chronic rhinosinusitis with nasal polyps and allergic fungal rhinosinusitis. Clin Exp Immunol (2011) 1.03
Cholecalciferol plus calcium suppresses abnormal PBMC reactivity in patients with multiple sclerosis. J Clin Endocrinol Metab (2011) 1.02
1,25-Dihydroxyvitamin D3 inhibits proliferation but not the suppressive function of regulatory T cells in the absence of antigen-presenting cells. Immunology (2011) 1.01
Vitamin D and multiple sclerosis. J Cell Biochem (2008) 0.99
Soluble mediators regulating immunity in early life. Front Immunol (2014) 0.99
Effects of vitamin A and D receptor gene polymorphisms/haplotypes on immune responses to measles vaccine. Pharmacogenet Genomics (2012) 0.98
Location, location, location: tissue-specific regulation of immune responses. J Leukoc Biol (2013) 0.96
Vitamin D: a new player in non-alcoholic fatty liver disease? World J Gastroenterol (2015) 0.96
Interaction of polysialic acid with CCL21 regulates the migratory capacity of human dendritic cells. PLoS One (2009) 0.96
Nuclear receptor signalling in dendritic cells connects lipids, the genome and immune function. EMBO J (2008) 0.96
Vitamin D and the epidemiology of upper gastrointestinal cancers: a critical analysis of the current evidence. Cancer Epidemiol Biomarkers Prev (2013) 0.96
Association of serum 25-hydroxyvitamin D with lifestyle factors and metabolic and cardiovascular disease markers: population-based cross-sectional study (FIN-D2D). PLoS One (2014) 0.95
Inverse regulation of the ADAM-family members, decysin and MADDAM/ADAM19 during monocyte differentiation. Immunology (2003) 0.95
Human tolerogenic DC-10: perspectives for clinical applications. Transplant Res (2012) 0.93
Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same? Clin Dev Immunol (2011) 0.92
Vitamin D for the prevention and treatment of pancreatic cancer. World J Gastroenterol (2009) 0.92
Hypovitaminosis D in adults with inflammatory bowel disease: potential role of ethnicity. Dig Dis Sci (2012) 0.91
Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis. World J Gastroenterol (2010) 0.91
Prevention of allograft rejection by amplification of Foxp3(+)CD4(+)CD25(+) regulatory T cells. Transl Res (2008) 0.91
Comparative therapeutic effects of orally administered 1,25-dihydroxyvitamin D(3) and 1alpha-hydroxyvitamin D(3) on type-1 diabetes in non-obese diabetic mice fed a normal-calcaemic diet. Clin Exp Immunol (2007) 0.91
Circulating pro-inflammatory cytokines are elevated and peak power output correlates with 25-hydroxyvitamin D in vitamin D insufficient adults. Eur J Appl Physiol (2013) 0.91
Dendritic cells transduced with lentiviral vectors expressing VIP differentiate into VIP-secreting tolerogenic-like DCs. Mol Ther (2010) 0.91
Disease activity, proteinuria, and vitamin D status in children with systemic lupus erythematosus and juvenile dermatomyositis. J Pediatr (2011) 0.91
Role of calcium, vitamin D, and the extrarenal vitamin D hydroxylases in carcinogenesis. Anticancer Agents Med Chem (2013) 0.90
Vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus. Mol Biol Rep (2012) 0.90
Vitamin D and gastrointestinal diseases: inflammatory bowel disease and colorectal cancer. Therap Adv Gastroenterol (2011) 0.90
Vitamin D and immunity. F1000Prime Rep (2014) 0.90
Phenotypic and functional markers for 1alpha,25-dihydroxyvitamin D(3)-modified regulatory dendritic cells. Clin Exp Immunol (2009) 0.90
Effect of vitamin D3 on phagocytic potential of macrophages with live Mycobacterium tuberculosis and lymphoproliferative response in pulmonary tuberculosis. J Clin Immunol (2004) 0.90
Vitamin D deficiency in chronic liver disease. World J Hepatol (2014) 0.89
Cell therapy using tolerogenic dendritic cells in transplantation. Transplant Res (2012) 0.89
Vitamin D and its emerging role in immunopathology. Clin Rheumatol (2011) 0.89
Vitamin D and the skin: Focus on a complex relationship: A review. J Adv Res (2014) 0.88
The active metabolite of leflunomide, A77 1726, interferes with dendritic cell function. Arthritis Res Ther (2005) 0.88
Vitamin D3 receptor is highly expressed in Hodgkin's lymphoma. BMC Cancer (2012) 0.88
Protective actions of vitamin D in UVB induced skin cancer. Photochem Photobiol Sci (2012) 0.88
Calcium and vitamin D in sarcoidosis: how to assess and manage. Semin Respir Crit Care Med (2010) 0.87
Dendritic cells a double-edge sword in autoimmune responses. Front Immunol (2012) 0.87
Curcumin induces maturation-arrested dendritic cells that expand regulatory T cells in vitro and in vivo. Clin Exp Immunol (2010) 0.87
Tolerogenic Donor-Derived Dendritic Cells Risk Sensitization In Vivo owing to Processing and Presentation by Recipient APCs. J Immunol (2013) 0.87
Can we translate vitamin D immunomodulating effect on innate and adaptive immunity to vaccine response? Nutrients (2015) 0.87
The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol (1998) 5.50
Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med (1997) 4.04
Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol (2001) 2.75
Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J Exp Med (1995) 2.29
Why peptides? Their possible role in the evolution of MHC-restricted T-cell recognition. Immunol Today (1989) 2.23
Fine specificity of regulatory T cells. II. Suppressor and helper T cells are induced by different regions of hen egg-white lysozyme in a genetically nonresponder mouse strain. J Exp Med (1979) 2.12
Different functional specificity repertoires for suppressor and helper T cells. Immunol Rev (1978) 1.91
Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells. J Immunol (2001) 1.82
Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: implications for myocardium regeneration. Proc Natl Acad Sci U S A (2001) 1.81
Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes. Immunol Today (2000) 1.77
Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J Clin Invest (1993) 1.73
Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM). J Exp Med (1999) 1.68
The role of Stat4 in species-specific regulation of Th cell development by type I IFNs. J Immunol (1998) 1.65
Capacity of intact proteins to bind to MHC class II molecules. J Immunol (1989) 1.63
Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and beta(2)-microglobulin-deficient BALB/c mice. J Exp Med (1996) 1.61
Dendritic cells but not B cells present antigenic complexes to class II-restricted T cells after administration of protein in adjuvant. J Exp Med (1996) 1.58
The control of T cell responses by dendritic cell subsets. Curr Opin Immunol (2000) 1.53
The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol Today (1995) 1.51
Chronic inflammation in the pathogenesis of benign prostatic hyperplasia. Int J Androl (2009) 1.43
The fine specificity of regulatory T cells. IV. Idiotypic complementarity and antigen-bridging interactions in the anti-lysozyme response. Eur J Immunol (1979) 1.42
Caspase-1 regulates the inflammatory process leading to autoimmune demyelination. J Immunol (1999) 1.42
Lysozyme-induced T-suppressor cells and antibodies have a predominant idiotype. Nature (1979) 1.40
Functional maturation of adult mouse resting microglia into an APC is promoted by granulocyte-macrophage colony-stimulating factor and interaction with Th1 cells. J Immunol (2000) 1.33
IL-12 production by central nervous system microglia is inhibited by astrocytes. J Immunol (1997) 1.31
IL-12: a key cytokine in immune regulation. Immunol Today (1996) 1.31
Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes. J Immunol (2001) 1.29
Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3). Eur J Immunol (2000) 1.28
Efficient immune responses in mice lacking N-region diversity. Eur J Immunol (1995) 1.22
Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. J Immunol (1998) 1.22
Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease. J Exp Med (1993) 1.19
Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells. J Immunol (1995) 1.19
Elocalcitol inhibits inflammatory responses in human thyroid cells and T cells. Endocrinology (2008) 1.18
Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice. J Immunol (1999) 1.14
Acceleration of intracellular targeting of antigen by the B-cell antigen receptor: importance depends on the nature of the antigen-antibody interaction. EMBO J (1997) 1.12
Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes. Eur J Immunol (1997) 1.10
Structural requirements for the interaction between peptide antigens and I-Ed molecules. J Immunol (1989) 1.09
IL-10 is required for development of protective Th1 responses in IL-12-deficient mice upon Candida albicans infection. J Immunol (1998) 1.09
A peptide-binding motif for I-A(g7), the class II major histocompatibility complex (MHC) molecule of NOD and Biozzi AB/H mice. J Exp Med (1997) 1.09
Selective vitamin D receptor modulators and their effects on colorectal tumor growth. J Steroid Biochem Mol Biol (2007) 1.08
Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen. J Immunol (1991) 1.04
The fine specificity of regulatory T cells. I. Hen egg-white lysozyme-induced suppressor T cells in a genetically nonresponder mouse strain do not recognize a closely related immunogenic lysozyme. J Immunol (1979) 1.04
Antigen presentation of hen egg-white lysozyme but not of ribonuclease A is augmented by the major histocompatibility complex class II-associated invariant chain. Eur J Immunol (1991) 1.02
A microcomputer program for probit analysis of interleukin-2 (IL-2) titration data. J Immunol Methods (1986) 1.00
The frequency of high avidity T cells determines the hierarchy of determinant spreading. J Immunol (2001) 1.00
CD40-CD154 interaction and IFN-gamma are required for IL-12 but not prostaglandin E2 secretion by microglia during antigen presentation to Th1 cells. J Immunol (1999) 1.00
Failure to demonstrate long-lived MHC saturation both in vitro and in vivo. Implications for therapeutic potential of MHC-blocking peptides. J Immunol (1994) 0.99
Comparison of structural requirements for interaction of the same peptide with I-Ek and I-Ed molecules in the activation of MHC class II-restricted T cells. J Immunol (1991) 0.98
In vivo restoration of T cell functions by human IL-1 beta or its 163-171 nonapeptide in immunodepressed mice. J Immunol (1988) 0.98
Colon cancer and solar ultraviolet B radiation and prevention and treatment of colon cancer in mice with vitamin D and its Gemini analogs. J Steroid Biochem Mol Biol (2005) 0.98
Polymorphisms in the Il12b gene affect structure and expression of IL-12 in NOD and other autoimmune-prone mouse strains. Genes Immun (2002) 0.97
Selective effects of ionizing radiations on immunoregulatory cells. Immunol Rev (1982) 0.97
Vitamin D receptor agonists inhibit pro-inflammatory cytokine production from the respiratory epithelium in cystic fibrosis. J Cyst Fibros (2011) 0.96
Prevention of autoimmune diabetes in non-obese diabetic mice by treatment with a class II major histocompatibility complex-blocking peptide. J Exp Med (1993) 0.94
Characterization of T-helper epitopes of the glycoprotein of vesicular stomatitis virus. J Virol (1994) 0.93
Enhancing effect of IFN-gamma on helper T cell activity and IL 2 production. J Immunol (1985) 0.93
Central nervous system delivery of interleukin 4 by a nonreplicative herpes simplex type 1 viral vector ameliorates autoimmune demyelination. Hum Gene Ther (1998) 0.92
Ultrasonographic and clinical correlates of seminal plasma interleukin-8 levels in patients attending an andrology clinic for infertility. Int J Androl (2010) 0.92
Epitope-specific enhancement of antigen presentation by invariant chain. J Exp Med (1993) 0.92
Glia-T cell dialogue. J Neuroimmunol (2000) 0.91
Relative efficiency of microglia, astrocytes, dendritic cells and B cells in naive CD4+ T cell priming and Th1/Th2 cell restimulation. Eur J Immunol (1999) 0.91
Normal B cells fail to secrete interleukin-12. Eur J Immunol (1997) 0.91
Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice. Gene Ther (2001) 0.91
Biological effects of Escherichia coli lipopolysaccharide (LPS) in vivo. I. Selection in the mouse thymus of killer and helper cells. Immunology (1976) 0.91
Selective in vivo inhibition of T cell activation by class II MHC-binding peptides administered in soluble form. J Immunol (1990) 0.90
New perspectives on immunointervention in autoimmune diseases. Immunol Today (1990) 0.90
Manipulating dendritic cells to induce regulatory T cells. Microbes Infect (2005) 0.90
Inhibition of prostate cell growth by BXL-628, a calcitriol analogue selected for a phase II clinical trial in patients with benign prostate hyperplasia. Eur J Endocrinol (2004) 0.90
Th1 cells induce and Th2 inhibit antigen-dependent IL-12 secretion by dendritic cells. Eur J Immunol (1998) 0.90
Rearrangement and expression of the alpha- and beta-chain genes of the T-cell antigen receptor in functional murine suppressor T-cell clones. Proc Natl Acad Sci U S A (1985) 0.88
Defective antigen presentation by macrophages from mice genetically selected for low antibody response. Eur J Immunol (1981) 0.88
Soluble protein but not peptide administration diverts the immune response of a clonal CD4+ T cell population to the T helper 2 cell pathway. J Immunol (1996) 0.88
Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis. Hum Gene Ther (2001) 0.88
Co-dominant restriction by a mixed-haplotype I-A molecule (alpha k beta b) for the lysozyme peptide 52-61 in H-2k x H-2b F1 mice. J Immunol (1990) 0.87
A miniaturized in vitro diffusion culture system. J Immunol Methods (1978) 0.87
Inhibition of T cell response with peptides is influenced by both peptide-binding specificity of major histocompatibility complex molecules and susceptibility of T cells to blocking. Eur J Immunol (1989) 0.87
Secretory defects induced by immunosuppressive agents on human pancreatic beta-cells. Acta Diabetol (2002) 0.87
Immunoregulation of lysozyme-specific suppression. II. Hen egg-white lysozyme-specific monoclonal suppressor T cell factor suppresses the afferent phase of delayed-type hypersensitivity and induces second-order suppressor T cells. Eur J Immunol (1984) 0.86
Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation. J Exp Med (1992) 0.86
Biological effects of Escherichia coli lipopolysaccharide (LPS) in vivo. II. Selection in the mouse thymus of PHA- and con A-responsive cells. Immunology (1976) 0.86
Vaccine T-cell epitope selection by a peptide competition assay. Proc Natl Acad Sci U S A (1989) 0.86
Production of antigen-specific suppressive T cell factor by radiation leukemia virus-transformed suppressor T cells. Proc Natl Acad Sci U S A (1981) 0.86
Constitutive presentation of dominant epitopes from endogenous naturally processed self-beta 2-microglobulin to class II-restricted T cells leads to self-tolerance. J Immunol (1995) 0.86
Fine antigenic specificity and genetic restriction of lysozyme-specific suppressor T cell factor produced by radiation leukemia virus-transformed suppressor T cells. Eur J Immunol (1982) 0.85
IL-12 receptor regulation in IL-12-deficient BALB/c and C57BL/6 mice. Eur J Immunol (2000) 0.85
MHC class II molecules bind indiscriminately self and non-self peptide homologs: effect on the immunogenicity of non-self peptides. Int Immunol (1993) 0.85
Disulfide-linked surface molecules of monoclonal antigen-specific suppressor T cells: evidence for T cell receptor structures. Eur J Immunol (1985) 0.84
IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease. Eur J Immunol (1998) 0.83
The involvement of IL-12 in murine experimentally induced autoimmune thyroid disease. Eur J Immunol (1999) 0.83
Elevated body mass index correlates with higher seminal plasma interleukin 8 levels and ultrasonographic abnormalities of the prostate in men attending an andrology clinic for infertility. J Endocrinol Invest (2011) 0.83
Th1 and Th2 cells. Res Immunol (1999) 0.83
The mode of protein antigen administration determines preferential presentation of peptide-class II complexes by lymph node dendritic or B cells. Int Immunol (1997) 0.83
Establishment of functional, antigen-specific T cell lines by radLV-induced transformation of murine T lymphocytes. Curr Top Microbiol Immunol (1982) 0.82
Enhanced frequency of mitogen-responsive T cell precursors in old mice injected with thymosin alpha 1. Eur J Immunol (1987) 0.82
Apoptosis: potential for disease therapies. Immunol Today (1998) 0.82
Selective immunosuppression of class II-restricted T cells by MHC class II-binding peptides. Crit Rev Immunol (1993) 0.82
Analysis of lysozyme-specific immune responses by synthetic peptides. I. Characterization of antibody and T cell-mediated responses to the N-terminal peptide of hen egg-white lysozyme. Eur J Immunol (1986) 0.81
The ependymal route to the CNS: an emerging gene-therapy approach for MS. Trends Immunol (2001) 0.81
DR alpha: E beta heterodimers in DRA transgenic mice hinder expression of E alpha: E beta molecules and are more efficient in antigen presentation. Int Immunol (1995) 0.81
MHC: orchestrating the immune response. Immunol Today (1995) 0.81